Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...

The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...

Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

Although evidence exists suggesting that some diseases causing neuropathic pain respond differently to the same medications, [85] we can conclude that it seems inevitable to base a treatment ...

A newly published study from Aarhus University Hospital shows that fecal microbiota transplantation (FMT)—a method where gut ...

The focus of traditional treatments on the symptoms rather than the condition has unfortunately made neuropathy a ...

A Manitoba woman is suing St. Boniface Hospital and two staff after undergoing a medical procedure that she says left her ...

Changes in the brain with cortical reorganisation to gut stimulation and increased activity in specific electroencephalographic features characteristic for neuropathic pain are also seen in patients ...

Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...

Neuropathic pain is caused by disorders of, or damage to, the nervous system. The affected nerves can induce the sensation of pain in the brain. Neuropathic pain is often associated with the ...